NINDS is supporting a database on COVID-19-related neurological symptoms and a repository for associated biosamples. Clinicians and health care organizations are invited to submit information on COVID 19-neurological complications and outcomes as well as COVID-19 effects on pre-existing neurological conditions seen in their patients. The COVID-19 Neuro Databank/Biobank (The NeuroCOVID Project), which was developed and will be maintained by NYU Langone Health, will be a resource of clinical information as well as biospecimens from people of all ages who have experienced a new onset neurological problems or worsening of existing neurological disorders associated with SARS-CoV-2 infection.
- Press release
- NYU NeuroCOVID Project website
- Frontiers in Neurology Perspective: The National Institutes of Health COVID-19 NeuroDatabank and NeuroBiobank: A National Resource for Learning, Discovery, and Progress (Published: Jan. 15, 2021)
COVID-19 and Neuroscience
Neurological Complications of COVID-19 and NINDS Clinical Research
October 20, 2020
Dr. Avindra Nath, NINDS Clinical Director, provides an overview of intramural research projects focused on the neurological manifestations of coronaviruses.
SfN Global Connectome: COVID + the Nervous System: A Conversation with NIH
January 11, 2021
The objectives of this event are to inform the community about what is known about the effects of SARS-CoV-2 on the nervous system; the effects of COVID-19 on those suffering from mental, neurological, or substance use disorders; and relevant NIH resources/funding opportunities focused on these effects. The format will include a roundtable with NIH Institute Directors, other leaders, and a Q&A with attendees. This event is a virtual social associated with the Society for Neuroscience Global Connectome.
Continue watching the remaining session here: SfN Global Connectome: COVID + the Nervous System: A Conversation with NIH